Physician profile
Maxim S Eckmann
NPI 1457470312
$349,380.05
in general payments reported to CMS, 2019-2025
28 companies · $66K in 2025
The $66K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59K · 2020: $32K · 2021: $36K · 2022: $42K · 2023: $50K · 2024: $63K · 2025: $66K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $91K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $33K · Consulting Fee: $29K · Travel and Lodging: $19K · Food and Beverage: $7,598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $91,093.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,052.50 |
| Consulting Fee | $28,681.79 |
| Travel and Lodging | $19,061.96 |
| Food and Beverage | $7,597.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $266,489.36 | 2019-2025 | Coolief* Cooled Radiofrequency, Coolief, Cooled Rfa |
| Vertex Pharmaceuticals Incorporated | $34,061.75 | 2024-2025 | |
| Brixton Biosciences, INC. | $15,071.15 | 2024-2025 | Neural Ice |
| Abbott Laboratories | $12,722.91 | 2019-2024 | Proclaim, Octrode, Eterna |
| Merck Sharp & Dohme LLC | $8,711.26 | 2025 | |
| Averitas Pharma INC. | $4,978.58 | 2023-2025 | Qutenza |
| Spinal Simplicity, LLC | $1,989.45 | 2022-2025 | Ha Minuteman G3-R |
| Nevro Corp. | $1,632.99 | 2019-2024 | Senza |
| Spr Therapeutics, INC | $971.90 | 2022-2025 | Sprint Pns System |
| Medtronic, INC. | $647.78 | 2021-2025 | Synchromedii, Kyphon Express II Kyphopak Tray, Osteocool Rf Ablation System |
| Boston Scientific Corporation | $447.47 | 2020-2025 | Wavewriter Alpha Prime 16, Intracept |
| Globus Medical, INC. | $322.77 | 2025 | Senza |
| Saluda Medical Americas, INC. | $229.20 | 2024-2025 | Evoke |
| Nalu Medical, INC. | $198.28 | 2021-2024 | Nalu Neurostimulation System |
| Si-Bone, INC. | $156.88 | 2020-2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $124.99 | 2025 | Exparel |
| Heron Therapeutics, INC. | $124.99 | 2025 | Zynrelef, Aponvie |
| Abbvie INC. | $105.25 | 2022-2024 | Botox |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Eagle Pharmaceuticals, INC. | $76.51 | 2024 | |
| Painteq LLC | $38.76 | 2023 | Painteq |
| Fisher & Paykel Healthcare INC | $35.69 | 2024-2025 | Fisher & Paykel Healthcare |
| Vertos Medical, INC. | $33.71 | 2023 | Mild Device Kit |
| Allergan, INC. | $29.24 | 2019 | |
| Biotronik Nro, INC. | $26.75 | 2024 | Prospera |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.71 | 2020 | |
| Medtronic USA, INC. | $20.56 | 2020 | |
| Stryker Corporation | $12.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maxim Eckmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.